Dr. Lal PathLabs

Dr. Lal PathLabs PEG

The PEG Ratio (Price/Earnings-to-Growth) of Dr. Lal PathLabs (LALPATHLAB.NS) as of Oct 25, 2026 is 1.55. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.61 — a change of -3.50% (lower).

PEG

1.55

YoY

-3.50%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Dr. Lal PathLabs is 2026 1.55 . PEG Ratio (Price/Earnings-to-Growth) of Dr. Lal PathLabs was 2025 1.61 . It decreases by -3.50% lower compared to the previous year.

The Dr. Lal PathLabs PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2019
3.94 INR
Jan 1, 2020
3.47 INR
Jan 1, 2021
2.69 INR
Jan 1, 2022
2.27 INR
Jan 1, 2023
3.28 INR
Jan 1, 2024
2.19 INR
Jan 1, 2025
1.61 INR
Jan 1, 2026
1.55 INR
The Dr. Lal PathLabs PEG history
YEARPEGYoY
1.55-3.50%
1.61-26.56%
2.19-33.23%
3.28+44.36%
2.27-15.42%
2.69-22.52%
3.47-11.84%
3.94-14.28%
4.59-9.46%
5.07-14.49%
5.93-27.62%
8.19-16.82%
9.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dr. Lal PathLabs Stock analysis

What does Dr. Lal PathLabs do? Dr. Lal PathLabs Ltd is a leading diagnostic company in India, offering a wide range of tests and services. The company was founded in 1949 by Dr. S.K. Lal in Delhi and has since expanded its services throughout India. Business Model: The business model of Dr. Lal PathLabs Ltd is based on offering diagnostic test packages for various diseases and disorders. Customers can choose from different test packages tailored to their specific needs. The company utilizes state-of-the-art technology and equipment in its laboratories to deliver accurate results. Another important pillar of the business model is close collaboration with doctors and clinics to improve customer care and provide comprehensive medical services. Company History: Dr. Lal PathLabs Ltd began its journey in 1949 in Delhi, India, when Dr. S.K. Lal founded the company. It was one of the few private laboratories capable of conducting diagnostic tests and was a pioneer in developing modern technology and equipment to support the tests. Over the years, the company has expanded its operations and services and is now one of the leading diagnostic companies in India. It is known for its precise test results, excellent customer care, and innovative technology. Segments: Dr. Lal PathLabs Ltd offers a wide range of diagnostic tests and services. The various segments covered by the company include: 1. Clinical Pathology: This segment covers a wide range of tests targeting the customers' health condition. They include blood tests, urine and stool tests, hormone tests, diabetes checks, pregnancy tests, and more. 2. Microbiology: This segment deals with the identification of pathogens such as bacteria, viruses, fungi, and parasites found in tests of body fluids and tissue samples. 3. Histology: This segment covers the identification of tissue samples and cells. It is used in the diagnosis of cancer, thyroid disorders, and other diseases. 4. Immunology: Tests are conducted based on antibodies to diagnose autoimmune diseases, infectious diseases, and allergies. 5. Genetics: This segment deals with the diagnosis of genetic diseases and genetic testing for disease prevention. Products: Dr. Lal PathLabs Ltd offers a wide range of diagnostic test packages customized to individual customer needs. Some of the key test packages include: 1. Pro 1: This test package provides a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, and uric acid. 2. Essential Health Checkup: This test package is designed for checking heart health and includes tests such as electrocardiogram (EKG), lipid profile, and complete blood count. 3. Diabetic Profile: This test package is specifically designed for diabetics and includes tests such as HbA1c, kidney function tests, and lipid profile. 4. Comprehensive Health Checkup: This test package offers a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, blood sugar, and uric acid. Dr. Lal PathLabs Ltd has established itself as a leading diagnostic company in India and is known for its high accuracy in test results and innovative technology. The company is committed to improving medical care and works closely with doctors and clinics to provide comprehensive medical services. Dr. Lal PathLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dr. Lal PathLabs stock

PEG Ratio (Price/Earnings-to-Growth) of Dr. Lal PathLabs is 1.55 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Dr. Lal PathLabs changed from 1.61 to 1.55, representing a -3.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Dr. Lal PathLabs since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Dr. Lal PathLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Dr. Lal PathLabs

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Dr. Lal PathLabs